NCT00393770View on ClinicalTrials.gov

Acetylcarnitine and Insulin Sensitivity

PHASE2CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

October 31, 2006

Study Completion Date

September 30, 2007

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

L-acetylcarnitine

250-500 mg/kg/die.

Trial Locations (1)

24020

Clinical Research Center for Rare Diseases, Ranica

All Listed Sponsors
lead

Mario Negri Institute for Pharmacological Research

OTHER

NCT00393770 - Acetylcarnitine and Insulin Sensitivity | Biotech Hunter | Biotech Hunter